Company intelligence / Profile preview

Stage 2 Capital

New York, New York, United States

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Stage 2 Capital is a venture capital firm that specializes in early-stage B2B software and go-to-market (GTM) strategy. Founded in 2018 by Mark Roberge and Jay Po, the firm is distinguished by its network of over 1,000 GTM executives who provide operational expertise and support to portfolio companies. While the firm invests broadly across B2B SaaS and AI, it maintains a presence in the healthcare sector through investments in healthcare IT and life sciences compliance software. Notable portfolio companies in the health space include MedScout, a revenue orchestration platform for medtech, and Ketryx, an AI-powered compliance platform for life sciences. The firm is headquartered in New York and operates with a unique 'pod' investment model that pairs financial expertise with operational GTM leadership.

Industry: Investors

Beyond the preview

Go deeper on Stage 2 Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stage 2 Capital.

Explore the full profile